Lifelong learning at our Virtual Campus Lifelong learning at our Virtual Campus The Virtual Campus of our Boehringer Ingelheim University supports our employees in their personalized lifelong learning.
Moving towards a rabies-free Southeast Asia Moving towards a rabies-free Southeast Asia Boehringer Ingelheim, in collaboration with Eco-Business, has published a comprehensive whitepaper to stop rabies.
Future Leaders in Veterinary Medicine and Research Future Leaders in Veterinary Medicine and Research Through the Boehringer Ingelheim Veterinary Scholars Program, we offer opportunities for students to gain research experience and explore new career paths.
New Partnership to Develop Gene Therapy for Cystic Fibrosis New Partnership to Develop Gene Therapy for Cystic Fibrosis Boehringer Ingelheim steps into the field of gene therapy with experienced partners to jointly develop first gene therapy for cystic fibrosis
Early careers Early careers At Boehringer Ingelheim, we know how important it is to lay the right foundations in your career and build on them with care and support.
Social innovation: catalyst for sustainable health solutions Social innovation: catalyst for sustainable health solutions Supporting social innovators drives sustainable health solutions in underserved communities. Learn more about Boehringer Ingelheim Social Engagements.
Combating food insecurity for more health equity in the U.S. Combating food insecurity for more health equity in the U.S. Meet social innovation founder Katie at Making More Health Together 2023: How the social innovation founder brings fresh food stores back to the U.S.
Living with heart failure Living with heart failure Hear Patricia’s story on the impact that heart failure can have on mental health and the importance of finding support networks.
Management Systems Management Systems Suppliers shall use management systems to support continuous improvement and compliance with the Supplier Code of Conduct.
Our mission in cardiovascular, renal, and metabolic care Our mission in cardiovascular, renal, and metabolic care Interconnected cardiovascular, renal, and metabolic diseases affect over 1 billion lives globally
Who are we? Who are we? Started in 1885 by Albert Boehringer, this independent family-owned company has grown into a top contributor in Human Pharma and Animal Health.
trust-through-transparency trust-through-transparency Transparency is an essential cornerstone of trust in the healthcare industry
Financial health Financial health We constantly review our salaries to make sure they stay competitive in each market but we also provide wider support for financial health.
Our Health and Safety initiative - BE SAFE Our Health and Safety initiative - BE SAFE Health and safety are of great importance to Boehringer Ingelheim.
Grass Roots Grass Roots Grass Roots Innovation: Championing the Next Generation of Life-Science Innovators
Cauliflower Risotto Video Cauliflower Risotto Video This creamy risotto is full of great flavours and is easy to make in batches for family and friends.
Lamb-shanks video Lamb-shanks video This succulent, heart dish is packed full of flavour and sure to be a hit with the whole family.
Improving Access to Stroke Care Improving Access to Stroke Care Angels Initiative named Best Practice example by the Access to Medicine Index
On the path to decarbonization: How we reduce our emissions On the path to decarbonization: How we reduce our emissions How our sites Fornovo and Paulínia became carbon-neutral and support our recently SBTi-validated 2030 goals
EFPIA Mission Possible EFPIA Mission Possible This new video highlights how treatments once known for type 2 diabetes are now helping to prevent heart failure, stroke or kidney disease.
ArisGlobal acquires Boehringer Ingelheim technology ArisGlobal acquires Boehringer Ingelheim technology Boehringer Ingelheim’s signal analytics technology is acquired by ArisGlobal
More Health: For People & Animals More Health: For People & Animals More Health: For People & Animals